国家重点监控药品合理用药管理规范

Rational use management standards of national key monitoring drug

目前,国家重点监控药品的合理使用管理缺乏统一的规范。为使国家重点监控药品在各级医疗机构更加合理使用和规范管理,根据国家的相关要求和近年来国内外发布的相关文献,并结合全国多家医疗机构对国家重点监控药品的管理实践,由中华医学会临床药学分会、中国药学会药物流行病学专委会及四川省药学会药物流行病学专委会组织专家充分讨论,形成《国家重点监控药品合理用药管理规范》。本规范主要内容包括重点监控药品的合理使用基本原则及重点监控药品监管办法,特别是怎样加强重点监控药品的药事管理和使用管理,旨在推动重点监控药品的规范使用,促进合理用药。

At present,there is a lack of unified and standardized management for the rational use of national key monitoring drugs.According to the relevant requirements of the state,based on the relevant literature published at home and abroad in recent years and combined with the management practice of many medical institutions across the country on the national key monitoring drugs,in order to make the national key monitoring drugs more reasonable use and standardized management in medical institutions at all levels,the Clinical Pharmacy Branch of the Chinese Medical Association,the Pharmaceutical Epidemiology Special Committee of the Chinese Pharmaceutical Association and the Pharmaceutical Epidemiology Special Committee of the Sichuan Pharmaceutical Association organized experts to fully discuss,and to form this management standard.This standard mainly provides relevant opinions and suggestions on the basic principles of rational use of key monitoring drugs and the regulatory measures for key monitoring drugs,especially on how to strengthen the pharmaceutical management and use management of key monitoring drugs,further promoting the standardized use of key monitoring drugs.